de Silva, T.I. and Malavige, G.N. (0AD) ‘Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic’, Sri Lanka Journal of Medicine, {volume}({issue}), p. {page}. Available at: https://doi.org/10.4038/sljm.v30i1.273.

de Silva, T Iand G N Malavige. “Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic”. Sri Lanka Journal of Medicine, vol. {volume}, no. {issue}, 0AD, p. {page}, doi:10.4038/sljm.v30i1.273.

de Silva, T. I., &amp; Malavige, G. N. (0AD). Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic. Sri Lanka Journal of Medicine, {volume}({issue}), {page}. https://doi.org/10.4038/sljm.v30i1.273

de Silva, T. I., and G. N. Malavige. 0AD. “Expansion of Sars-cov-2 Sequencing Capacity Globally Is Vital for Future Control of the COVID-19 Pandemic”. Sri Lanka Journal of Medicine {volume} ({issue}): {page}. https://doi.org/10.4038/sljm.v30i1.273.

1. de Silva TI, Malavige GN. Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic. Sri Lanka Journal of Medicine. 0AD;{volume}({issue}):{page}. DOI: https://doi.org/10.4038/sljm.v30i1.273

1. de Silva TI, Malavige GN. Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic. Sri Lanka Journal of Medicine. 0AD;{volume}({issue}):{page}. doi:10.4038/sljm.v30i1.273

de Silva TI and Malavige GN, ‘Expansion of Sars-cov-2 Sequencing Capacity Globally Is Vital for Future Control of the COVID-19 Pandemic’ (0AD) {volume} Sri Lanka Journal of Medicine {page} DOI: https://doi.org/10.4038/sljm.v30i1.273

[1]T. I. de Silva and G. N. Malavige, “Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic”, Sri Lanka Journal of Medicine, vol. {volume}, no. {issue}, p. {page}, 0AD, doi: 10.4038/sljm.v30i1.273.

This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 license (unless stated otherwise) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Editorial

Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic

Authors:

Abstract